SCHEMBL6988090

SCHEMBL6988090

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(Br)cc1)c1cccc(O)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.35
NPC1 O15118 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
CYP3A4 P08684 2/20 0.34
TSHR P16473 2/20 0.34
CYP24A1 Q07973 1/20 0.33
HPGDS O60760 1/20 0.32
PTGFR P43088 7/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32
PLD1 Q13393 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990359 0.92 HPGD (0.38) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL6985507 0.92 SMN1; SMN2 (0.37) TP53NPC1RAB9AOPRM1OPRD1
SCHEMBL6987228 0.91 CTSK (0.37) TP53RAB9AOPRD1LMNAMAPT
SCHEMBL6990344 0.90 MEN1 (0.37) NPC1RAB9AOPRM1OPRD1KMT2A
SCHEMBL6986649 0.90 HTR1A (0.40) TP53NPC1MAPK1KMT2AALDH1A1
SCHEMBL6988403 0.89 KMT2A (0.35) NPC1RAB9AOPRM1OPRD1KMT2A
SCHEMBL6991034 0.89 TAS1R3 (0.34) OPRM1OPRD1CYP3A4HPGDSPLD1
SCHEMBL6989479 0.88 ATM (0.39) NPC1MAPK1RAB9AKMT2ALMNA
SCHEMBL6988282 0.87 TRPV1 (0.41)
SCHEMBL6988331 0.86 KDM1A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed